RaySearch Laboratories Ownership
| RSLBF Stock | USD 26.74 2.74 11.42% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
RaySearch |
RaySearch Pink Sheet Ownership Analysis
About 56.0% of the company shares are owned by institutional investors. The book value of RaySearch Laboratories was at this time reported as 2.05. The company last dividend was issued on the 18th of May 2016. RaySearch Laboratories had 3:1 split on the 25th of June 2008. RaySearch Laboratories AB , a medical technology company, develops software solutions for cancer treatment worldwide. RaySearch Laboratories AB is headquartered in Stockholm, Sweden. Raysearch Laboratories operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 389 people.The quote for RaySearch Laboratories AB is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about RaySearch Laboratories AB contact Johan Lof at 46 8 51 05 30 00 or learn more at https://www.raysearchlabs.com.Currently Active Assets on Macroaxis
Other Information on Investing in RaySearch Pink Sheet
RaySearch Laboratories financial ratios help investors to determine whether RaySearch Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RaySearch with respect to the benefits of owning RaySearch Laboratories security.